Plus   Neg

Stock Alert: Youdao Rises On Better Quarterly Results

Shares of e-learning company Youdao, Inc. (DAO) are climbing more than 8% on the back of upbeat first-quarter results.

The company's loss on an adjusted basis narrowed to RMB1.45 (US$0.20) per ADS compared with RMB1.10 for the same period last year.

Revenue for the quarter increased 139.8% year-over-year at RMB541.4 million (US$76.5 million).

Gross billings of online courses increased by 287% year-over-year to RMB519 million.

Youdao stock gained nearly 90% in the recent months, currently trading at $28.70, close to its 52-week high of $29.50.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT